Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,500 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 7 September 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at so that we can update the bibliography.


 (PDF, 3MB, 209 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website



Export 15 results:
Author Title [ Type(Desc)] Year
Filters: Author is Price, D.  [Clear All Filters]
Journal Article
C. C. Winchester, Macfarlane, T. V., Thomas, M., and Price, D., Antibiotic prescribing and outcomes of lower respiratory tract infection in UK primary care, Chest, vol. 135, pp. 1163-1172, 2009.
K. Kostikas, Price, D., Gutzwiller, F. S., Jones, B., Loefroth, E., Clemens, A., Fogel, R., Jones, R., and Cao, H., Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database, Int J Chron Obstruct Pulmon Dis, vol. 15, pp. 1729-1738, 2020.
J. Griffin, Lee, S., Caiado, M., Kesten, S., and Price, D., Comparison of tiotropium bromide and combined ipratropium/salbutamol for the treatment of COPD: a UK General Practice Research Database 12-month follow-up study, Prim Care Respir J, vol. 17, pp. 104-10, 2008.
D. Price, Haughney, J., Sims, E., Ali, M., von Ziegenweidt, J., Hillyer, E. V., Lee, A. J., Chisholm, A., and Barnes, N., Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD, J Asthma Allergy, vol. 4, pp. 37-47, 2011.
M. Happich, Kirson, N. Y., Desai, U., King, S., Birnbaum, H. G., Reed, C., Belger, M., Lenox-Smith, A., and Price, D., Excess Costs Associated with Possible Misdiagnosis of Alzheimer's Disease Among Patients with Vascular Dementia in a UK CPRD Population, J Alzheimers Dis, vol. 53, pp. 171-83, 2016.
A. Ruigomez, Rodriguez, L. A., Wallander, M. A., Johansson, S., Thomas, M., and Price, D., Gastroesophageal reflux disease and asthma: a longitudinal study in UK general practice, Chest, vol. 128, pp. 85-93, 2005.
M. Thomas, von Ziegenweidt, J., Lee, A. J., and Price, D., High-dose inhaled corticosteroids versus add-on long-acting beta-agonists in asthma: an observational study, J Allergy Clin Immunol, vol. 123, pp. 116-121.e10, 2009.
M. Thomas, Price, D., Chrystyn, H., Lloyd, A., Williams, A. E., and von Ziegenweidt, J., Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control, BMC Pulm Med, vol. 9, p. 1, 2009.
S. W. Turner, Richardson, K., Burden, A., Thomas, M., Murray, C., and Price, D., Initial step-up treatment changes in asthmatic children already prescribed inhaled corticosteroids: a historical cohort study, NPJ Prim Care Respir Med, vol. 25, p. 15041, 2015.
R. C. Jones, Price, D., Ryan, D., Sims, E. J., von Ziegenweidt, J., Mascarenhas, L., Burden, A., Halpin, D. M., Winter, R., Hill, S., Kearney, M., Holton, K., Moger, A., Freeman, D., Chisholm, A., and Bateman, E. D., Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort, Lancet Respir Med, vol. 2, pp. 267-76, 2014.
D. Price, Wilson, A. M., Chisholm, A., Rigazio, A., Burden, A., Thomas, M., and King, C., Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice, J Asthma Allergy, vol. 9, pp. 1-12, 2016.
S. Turner, Thomas, M., von Ziegenweidt, J., and Price, D., Prescribing trends in asthma: a longitudinal observational study, Arch Dis Child, vol. 94, pp. 16-22, 2009.
J. van Boven, Benhaddi, H., Roche, N., Bjermer, L., Miravitlles, M., Voorham, J., and Price, D., Real-world cost effectiveness comparison of symbicort turbuhaler and duoresp spiromax in UK patients with asthma or chronic obstructive pulmonary disease, Value in Health, vol. 20, p. A645, 2017.
D. Price, Thomas, V., von Ziegenweidt, J., Gould, S., Hutton, C., and King, C., Switching patients from other inhaled corticosteroid devices to the Easyhaler((R)): historical, matched-cohort study of real-life asthma patients, J Asthma Allergy, vol. 7, pp. 31-51, 2014.
D. C. Gibbons, Aggarwal, B., Fairburn-Beech, J., Hinds, D., Fletcher, M., Bosnic-Anticevich, S., and Price, D., Treatment patterns among non-active users of maintenance asthma medication in the United Kingdom: a retrospective cohort study in the Clinical Practice Research Datalink, J Asthma, pp. 1-12, 2020.
[Page last reviewed 7 September 2020]